Cell & Gene Therapies: Can We Find Innovative Ways to Pay?
Join OHE experts in Boston as they provide insights into innovative approaches to reimbursement for cell and gene therapies
10/05/23 09:00 am
Massbio, Boston, Usa
No Events Found
The curative nature of cell and gene therapies has the potential to transform our entire approach to healthcare. Approvals have so far been in niche indications but the successful application of similar technologies in broader indications is expected to follow.
As the list of approvals grows, so too does the pressure on payers. The record-breaking price tags for these innovative therapies reflect the savings in medical costs over time, but the sizable upfront costs could create significant challenges for the reimbursement system.
The UK’s Office of Health Economics (OHE) has conducted extensive research into tackling the unique challenges that cell and gene therapies create for industry, regulators, and payors. This event provides an opportunity to hear from our experts on:
Innovative approaches to reimbursement
Demonstrating the value of cell and gene therapies
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!